{"id":866694,"date":"2025-07-07T04:10:32","date_gmt":"2025-07-07T08:10:32","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/hims-hers-health-inc-securities-fraud-class-action-lawsuit-pending-contact-wolf-haldenstein-before-august-25-2025-to-discuss-your-rights-2\/"},"modified":"2025-07-07T04:10:32","modified_gmt":"2025-07-07T08:10:32","slug":"hims-hers-health-inc-securities-fraud-class-action-lawsuit-pending-contact-wolf-haldenstein-before-august-25-2025-to-discuss-your-rights-2","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/hims-hers-health-inc-securities-fraud-class-action-lawsuit-pending-contact-wolf-haldenstein-before-august-25-2025-to-discuss-your-rights-2\/","title":{"rendered":"Hims &amp; Hers Health, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Wolf Haldenstein Before August 25, 2025 to Discuss Your Rights"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <span class=\"legendSpanClass\"><br \/>\n          <span class=\"xn-location\">NEW YORK<\/span><br \/>\n        <\/span>, <span class=\"legendSpanClass\"><span class=\"xn-chron\">July 7, 2025<\/span><\/span> \/PRNewswire\/ &#8212;\u00a0<a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4461682-3&amp;h=963627848&amp;u=https%3A%2F%2Fwww.whafh.com%2Fcase%2Fhims-hers-health-inc-nyse-hims%2F&amp;a=Wolf+Haldenstein+Adler+Freeman+%26+Herz+LLP\" target=\"_blank\" rel=\"nofollow\"><span class=\"xn-person\">Wolf Haldenstein Adler Freeman<\/span> &amp; Herz LLP<\/a> announces that a securities class action lawsuit has been filed on behalf of all investors who purchased or otherwise acquired securities of Hims &amp; Hers Health, Inc. (NYSE: HIMS) (&#8220;Hims &amp; Hers&#8221; or the &#8220;Company&#8221;) securities between <span class=\"xn-chron\">April 29, 2025<\/span> and <span class=\"xn-chron\">June 23, 2025<\/span>, inclusive (the &#8220;Class Period&#8221;).<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder1\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/1064977\/Wolf_Haldenstein_Adler_Freeman_Logo.html\" target=\"_blank\" rel=\"nofollow\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/1064977\/Wolf_Haldenstein_Adler_Freeman_Logo.jpg\" title=\"(PRNewsfoto\/Wolf Haldenstein Adler Freeman )\" alt=\"(PRNewsfoto\/Wolf Haldenstein Adler Freeman )\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<p>\n        <b>Investors who purchased or otherwise acquired shares of Hims &amp; Hers should contact the <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4461682-3&amp;h=2209529358&amp;u=https%3A%2F%2Fwww.whafh.com%2Fcase%2Frocket-pharmaceuticals-inc-nasdaq-rckt%2F&amp;a=Firm\" target=\"_blank\" rel=\"nofollow\">Firm<\/a> prior to the <span class=\"xn-chron\">August 25, 2025<\/span> lead plaintiff motion deadline.<\/b>\n      <\/p>\n<p class=\"prntac\">\n        <b><br \/>\n          <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4461682-3&amp;h=73902883&amp;u=https%3A%2F%2Fwww.whafh.com%2Fcase%2Fhims-hers-health-inc-nyse-hims%2F&amp;a=PLEASE+CLICK+HERE+TO+JOIN+THE+CASE+AND+SUBMIT+CONTACT+INFORMATION\" target=\"_blank\" rel=\"nofollow\">PLEASE CLICK HERE TO JOIN THE CASE AND SUBMIT CONTACT INFORMATION<\/a><br \/>\n        <\/b>\n      <\/p>\n<p>\n        <b>CLASS PERIOD<\/b>: <span class=\"xn-chron\">April 29, 2025<\/span> to <span class=\"xn-chron\">June 23, 2025<\/span><\/p>\n<p>\n        <b>ALLEGATIONS<\/b>: Hims &amp; Hers is a telehealth company that provides prescription medications, over-the-counter medications, and personal care products. According to the filed complaint, on <span class=\"xn-chron\">April 29, 2025<\/span>, Hims &amp; Hers announced a long-term collaboration with Novo Nordisk A\/S, starting with the immediate sale of <i>&#8220;a bundled offering of Novo Nordisk&#8217;s FDA-approved Wegovy\u00ae on the Hims &amp; Hers platform.&#8221;<\/i><\/p>\n<p>The\u00a0Hims &amp; Hers\u00a0class action lawsuit <span>alleges<\/span> that defendants throughout the Class Period made false and\/or misleading statements and\/or failed to disclose that:<\/p>\n<ul type=\"disc\">\n<li>Hims &amp; Hers was engaged in the <i>&#8220;deceptive promotion and selling of illegitimate, knockoff versions of Wegovy\u00ae that put patient safety at risk<\/i>&#8220;; and\n<\/li>\n<li>as a result, there was a substantial risk that Hims &amp; Hers&#8217; collaboration with Novo Nordisk would be terminated.<\/li>\n<\/ul>\n<p>The\u00a0Hims &amp; Hers\u00a0lawsuit further <span>alleges<\/span> that on <span class=\"xn-chron\">June 23, 2025<\/span>, <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4461682-3&amp;h=4010072769&amp;u=https%3A%2F%2Fwww.prnewswire.com%2Fnews-releases%2Fnovo-nordisk-terminates-collaboration-with-hims--hers-health-inc-due-to-concerns-about-their-illegal-mass-compounding-and-deceptive-marketing-302488189.html&amp;a=Novo+Nordisk+issued+a+press+release+announcing+that+it+was+terminating+its+partnership+with+Hims+%26+Hers\" target=\"_blank\" rel=\"nofollow\">Novo Nordisk issued a press release announcing that it was terminating its partnership with Hims &amp; Hers<\/a>\u00a0<i>&#8220;based on Hims &amp; Hers deceptive promotion and selling of illegitimate, knockoff versions of Wegovy\u00ae that put patient safety at risk.&#8221;<\/i>\u00a0<\/p>\n<p>On this news, the price of Hims &amp; Hers stock fell <span class=\"xn-money\">$18.26<\/span> per share, to close at <span class=\"xn-money\">$45.00<\/span> per share, a decline of more than 34%.<\/p>\n<p>\n        <b>DEADLINE<\/b>: <span class=\"xn-chron\">August 25, 2025<\/span>. Shareholders should contact <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4461682-3&amp;h=821962856&amp;u=https%3A%2F%2Fwww.whafh.com%2Fcase%2Fhims-hers-health-inc-nyse-hims%2F&amp;a=Wolf+Haldenstein\" target=\"_blank\" rel=\"nofollow\"><span class=\"xn-person\">Wolf Haldenstein<\/span><\/a> as soon as possible<\/p>\n<p>\n        <b>Why\u00a0<\/b><br \/>\n        <b><br \/>\n          <u><br \/>\n            <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4461682-3&amp;h=963627848&amp;u=https%3A%2F%2Fwww.whafh.com%2Fcase%2Fhims-hers-health-inc-nyse-hims%2F&amp;a=Wolf+Haldenstein+Adler+Freeman+%26+Herz+LLP\" target=\"_blank\" rel=\"nofollow\"><br \/>\n              <span class=\"xn-person\">Wolf Haldenstein Adler Freeman<\/span> &amp; Herz LLP<\/a><br \/>\n          <\/u><br \/>\n        <\/b><br \/>\n        <b>?<\/b><br \/>\n        <b>:<\/b>\n      <\/p>\n<p>This illustrious\u00a0<a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4461682-3&amp;h=3509870710&amp;u=https%3A%2F%2Fwww.whafh.com%2Fcase%2Fhims-hers-health-inc-nyse-hims%2F&amp;a=firm%2C\" target=\"_blank\" rel=\"nofollow\">firm,<\/a>\u00a0founded in 1888, is steadfast in their pursuit of justice for investors who have suffered financial harm due to these misrepresented statements.\u00a0The <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4461682-3&amp;h=157412048&amp;u=https%3A%2F%2Fwww.whafh.com%2Fcase%2Fpepgen-inc-nasdaq-pepg%2F&amp;a=law+firm%C2%A0\" target=\"_blank\" rel=\"nofollow\">law firm\u00a0<\/a>brings to the fore over 125 years of legal expertise in securities litigation and has a proven track record of protecting the rights of investors.<\/p>\n<p>We encourage all investors who have been suffered losses or have information that will assist in our investigation, to contact\u00a0<a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4461682-3&amp;h=1570232301&amp;u=https%3A%2F%2Fwww.whafh.com%2Fcase%2Fhims-hers-health-inc-nyse-hims%2F&amp;a=Wolf+Haldenstein+Adler+Freeman+%26+Herz+LLP.\" target=\"_blank\" rel=\"nofollow\"><span class=\"xn-person\">Wolf Haldenstein Adler Freeman<\/span> &amp; Herz LLP.<\/a><\/p>\n<p>\n        <b>Contact:<\/b>\n      <\/p>\n<ul type=\"disc\">\n<li>\n          <b>Phone:<\/b>\u00a0(800) 575-0735 or (212) 545-4774<\/p>\n<\/li>\n<li>\n          <b>Email:\u00a0<\/b><br \/>\n          <a href=\"mailto:classmember@whafh.com\" target=\"_blank\" rel=\"nofollow\">classmember@whafh.com<\/a><\/p>\n<\/li>\n<li>\n          <b>Contact Person:<\/b>\u00a0<a href=\"mailto:gstone@whafh.com\" target=\"_blank\" rel=\"nofollow\"><span class=\"xn-person\">Gregory Stone<\/span>, Director of Case and Financial Analysis<\/a><\/li>\n<\/ul>\n<p>\n        <b>Firm Website:<\/b>\u00a0<a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4461682-3&amp;h=963627848&amp;u=https%3A%2F%2Fwww.whafh.com%2Fcase%2Fhims-hers-health-inc-nyse-hims%2F&amp;a=Wolf+Haldenstein+Adler+Freeman+%26+Herz+LLP\" target=\"_blank\" rel=\"nofollow\"><span class=\"xn-person\">Wolf Haldenstein Adler Freeman<\/span> &amp; Herz LLP<\/a><\/p>\n<p>This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.<\/p>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=NY23407&amp;sd=2025-07-07\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow\" href=\"https:\/\/www.prnewswire.com\/news-releases\/hims--hers-health-inc-securities-fraud-class-action-lawsuit-pending-contact-wolf-haldenstein-before-august-25-2025-to-discuss-your-rights-302497280.html\" target=\"_blank\">https:\/\/www.prnewswire.com\/news-releases\/hims&#8211;hers-health-inc-securities-fraud-class-action-lawsuit-pending-contact-wolf-haldenstein-before-august-25-2025-to-discuss-your-rights-302497280.html<\/a><\/p>\n<p>SOURCE  <span class=\"xn-person\">Wolf Haldenstein Adler Freeman<\/span> &amp; Herz LLP<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=NY23407&amp;Transmission_Id=202507070404PR_NEWS_USPR_____NY23407&amp;DateId=20250707\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire NEW YORK , July 7, 2025 \/PRNewswire\/ &#8212;\u00a0Wolf Haldenstein Adler Freeman &amp; Herz LLP announces that a securities class action lawsuit has been filed on behalf of all investors who purchased or otherwise acquired securities of Hims &amp; Hers Health, Inc. (NYSE: HIMS) (&#8220;Hims &amp; Hers&#8221; or the &#8220;Company&#8221;) securities between April 29, 2025 and June 23, 2025, inclusive (the &#8220;Class Period&#8221;). Investors who purchased or otherwise acquired shares of Hims &amp; Hers should contact the Firm prior to the August 25, 2025 lead plaintiff motion deadline. PLEASE CLICK HERE TO JOIN THE CASE AND SUBMIT CONTACT INFORMATION CLASS PERIOD: April 29, 2025 to June 23, 2025 ALLEGATIONS: Hims &amp; Hers is a telehealth company that provides prescription &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/hims-hers-health-inc-securities-fraud-class-action-lawsuit-pending-contact-wolf-haldenstein-before-august-25-2025-to-discuss-your-rights-2\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Hims &amp; Hers Health, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Wolf Haldenstein Before August 25, 2025 to Discuss Your Rights&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-866694","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Hims &amp; Hers Health, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Wolf Haldenstein Before August 25, 2025 to Discuss Your Rights - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/hims-hers-health-inc-securities-fraud-class-action-lawsuit-pending-contact-wolf-haldenstein-before-august-25-2025-to-discuss-your-rights-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Hims &amp; Hers Health, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Wolf Haldenstein Before August 25, 2025 to Discuss Your Rights - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire NEW YORK , July 7, 2025 \/PRNewswire\/ &#8212;\u00a0Wolf Haldenstein Adler Freeman &amp; Herz LLP announces that a securities class action lawsuit has been filed on behalf of all investors who purchased or otherwise acquired securities of Hims &amp; Hers Health, Inc. (NYSE: HIMS) (&#8220;Hims &amp; Hers&#8221; or the &#8220;Company&#8221;) securities between April 29, 2025 and June 23, 2025, inclusive (the &#8220;Class Period&#8221;). Investors who purchased or otherwise acquired shares of Hims &amp; Hers should contact the Firm prior to the August 25, 2025 lead plaintiff motion deadline. PLEASE CLICK HERE TO JOIN THE CASE AND SUBMIT CONTACT INFORMATION CLASS PERIOD: April 29, 2025 to June 23, 2025 ALLEGATIONS: Hims &amp; Hers is a telehealth company that provides prescription &hellip; Continue reading &quot;Hims &amp; Hers Health, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Wolf Haldenstein Before August 25, 2025 to Discuss Your Rights&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/hims-hers-health-inc-securities-fraud-class-action-lawsuit-pending-contact-wolf-haldenstein-before-august-25-2025-to-discuss-your-rights-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-07-07T08:10:32+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/1064977\/Wolf_Haldenstein_Adler_Freeman_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hims-hers-health-inc-securities-fraud-class-action-lawsuit-pending-contact-wolf-haldenstein-before-august-25-2025-to-discuss-your-rights-2\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hims-hers-health-inc-securities-fraud-class-action-lawsuit-pending-contact-wolf-haldenstein-before-august-25-2025-to-discuss-your-rights-2\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Hims &amp; Hers Health, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Wolf Haldenstein Before August 25, 2025 to Discuss Your Rights\",\"datePublished\":\"2025-07-07T08:10:32+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hims-hers-health-inc-securities-fraud-class-action-lawsuit-pending-contact-wolf-haldenstein-before-august-25-2025-to-discuss-your-rights-2\\\/\"},\"wordCount\":480,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hims-hers-health-inc-securities-fraud-class-action-lawsuit-pending-contact-wolf-haldenstein-before-august-25-2025-to-discuss-your-rights-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1064977\\\/Wolf_Haldenstein_Adler_Freeman_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hims-hers-health-inc-securities-fraud-class-action-lawsuit-pending-contact-wolf-haldenstein-before-august-25-2025-to-discuss-your-rights-2\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hims-hers-health-inc-securities-fraud-class-action-lawsuit-pending-contact-wolf-haldenstein-before-august-25-2025-to-discuss-your-rights-2\\\/\",\"name\":\"Hims &amp; Hers Health, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Wolf Haldenstein Before August 25, 2025 to Discuss Your Rights - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hims-hers-health-inc-securities-fraud-class-action-lawsuit-pending-contact-wolf-haldenstein-before-august-25-2025-to-discuss-your-rights-2\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hims-hers-health-inc-securities-fraud-class-action-lawsuit-pending-contact-wolf-haldenstein-before-august-25-2025-to-discuss-your-rights-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1064977\\\/Wolf_Haldenstein_Adler_Freeman_Logo.jpg\",\"datePublished\":\"2025-07-07T08:10:32+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hims-hers-health-inc-securities-fraud-class-action-lawsuit-pending-contact-wolf-haldenstein-before-august-25-2025-to-discuss-your-rights-2\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hims-hers-health-inc-securities-fraud-class-action-lawsuit-pending-contact-wolf-haldenstein-before-august-25-2025-to-discuss-your-rights-2\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hims-hers-health-inc-securities-fraud-class-action-lawsuit-pending-contact-wolf-haldenstein-before-august-25-2025-to-discuss-your-rights-2\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1064977\\\/Wolf_Haldenstein_Adler_Freeman_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1064977\\\/Wolf_Haldenstein_Adler_Freeman_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hims-hers-health-inc-securities-fraud-class-action-lawsuit-pending-contact-wolf-haldenstein-before-august-25-2025-to-discuss-your-rights-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Hims &amp; Hers Health, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Wolf Haldenstein Before August 25, 2025 to Discuss Your Rights\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Hims &amp; Hers Health, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Wolf Haldenstein Before August 25, 2025 to Discuss Your Rights - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/hims-hers-health-inc-securities-fraud-class-action-lawsuit-pending-contact-wolf-haldenstein-before-august-25-2025-to-discuss-your-rights-2\/","og_locale":"en_US","og_type":"article","og_title":"Hims &amp; Hers Health, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Wolf Haldenstein Before August 25, 2025 to Discuss Your Rights - Market Newsdesk","og_description":"PR Newswire NEW YORK , July 7, 2025 \/PRNewswire\/ &#8212;\u00a0Wolf Haldenstein Adler Freeman &amp; Herz LLP announces that a securities class action lawsuit has been filed on behalf of all investors who purchased or otherwise acquired securities of Hims &amp; Hers Health, Inc. (NYSE: HIMS) (&#8220;Hims &amp; Hers&#8221; or the &#8220;Company&#8221;) securities between April 29, 2025 and June 23, 2025, inclusive (the &#8220;Class Period&#8221;). Investors who purchased or otherwise acquired shares of Hims &amp; Hers should contact the Firm prior to the August 25, 2025 lead plaintiff motion deadline. PLEASE CLICK HERE TO JOIN THE CASE AND SUBMIT CONTACT INFORMATION CLASS PERIOD: April 29, 2025 to June 23, 2025 ALLEGATIONS: Hims &amp; Hers is a telehealth company that provides prescription &hellip; Continue reading \"Hims &amp; Hers Health, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Wolf Haldenstein Before August 25, 2025 to Discuss Your Rights\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/hims-hers-health-inc-securities-fraud-class-action-lawsuit-pending-contact-wolf-haldenstein-before-august-25-2025-to-discuss-your-rights-2\/","og_site_name":"Market Newsdesk","article_published_time":"2025-07-07T08:10:32+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/1064977\/Wolf_Haldenstein_Adler_Freeman_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hims-hers-health-inc-securities-fraud-class-action-lawsuit-pending-contact-wolf-haldenstein-before-august-25-2025-to-discuss-your-rights-2\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hims-hers-health-inc-securities-fraud-class-action-lawsuit-pending-contact-wolf-haldenstein-before-august-25-2025-to-discuss-your-rights-2\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Hims &amp; Hers Health, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Wolf Haldenstein Before August 25, 2025 to Discuss Your Rights","datePublished":"2025-07-07T08:10:32+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hims-hers-health-inc-securities-fraud-class-action-lawsuit-pending-contact-wolf-haldenstein-before-august-25-2025-to-discuss-your-rights-2\/"},"wordCount":480,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hims-hers-health-inc-securities-fraud-class-action-lawsuit-pending-contact-wolf-haldenstein-before-august-25-2025-to-discuss-your-rights-2\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/1064977\/Wolf_Haldenstein_Adler_Freeman_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hims-hers-health-inc-securities-fraud-class-action-lawsuit-pending-contact-wolf-haldenstein-before-august-25-2025-to-discuss-your-rights-2\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/hims-hers-health-inc-securities-fraud-class-action-lawsuit-pending-contact-wolf-haldenstein-before-august-25-2025-to-discuss-your-rights-2\/","name":"Hims &amp; Hers Health, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Wolf Haldenstein Before August 25, 2025 to Discuss Your Rights - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hims-hers-health-inc-securities-fraud-class-action-lawsuit-pending-contact-wolf-haldenstein-before-august-25-2025-to-discuss-your-rights-2\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hims-hers-health-inc-securities-fraud-class-action-lawsuit-pending-contact-wolf-haldenstein-before-august-25-2025-to-discuss-your-rights-2\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/1064977\/Wolf_Haldenstein_Adler_Freeman_Logo.jpg","datePublished":"2025-07-07T08:10:32+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hims-hers-health-inc-securities-fraud-class-action-lawsuit-pending-contact-wolf-haldenstein-before-august-25-2025-to-discuss-your-rights-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/hims-hers-health-inc-securities-fraud-class-action-lawsuit-pending-contact-wolf-haldenstein-before-august-25-2025-to-discuss-your-rights-2\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hims-hers-health-inc-securities-fraud-class-action-lawsuit-pending-contact-wolf-haldenstein-before-august-25-2025-to-discuss-your-rights-2\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/1064977\/Wolf_Haldenstein_Adler_Freeman_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/1064977\/Wolf_Haldenstein_Adler_Freeman_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hims-hers-health-inc-securities-fraud-class-action-lawsuit-pending-contact-wolf-haldenstein-before-august-25-2025-to-discuss-your-rights-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Hims &amp; Hers Health, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Wolf Haldenstein Before August 25, 2025 to Discuss Your Rights"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/866694","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=866694"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/866694\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=866694"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=866694"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=866694"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}